Cited by 250Influenza Virus Research StudiesRespiratory viral infections researchVaccine Coverage and Hesitancy

The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.

Effectiveness of influenza vaccines in preventing severe influenza illness among adults: A systematic review and meta- analysis of test-negative design case-control studies

Open access

Rondy, Marc, El Omeiri, Nathalie, Thompson, Mark G., Levêque, Alain, Moren, Alain, Sullivan, Sheena G.·2017·Journal of Infection

DOI 10.1016/j.jinf.2017.09.010PMC PMC5912669

Open this paper in CoChat — free account

Abstract

Objectives Summary evidence of influenza vaccine effectiveness (IVE) against hospitalized influenza is lacking. We conducted a meta-analysis of studies reporting IVE against laboratory-confirmed hospitalized influenza among adults.Methods We searched Pubmed (January 2009 to November 2016) for studies that used test-negative design (TND) to enrol patients hospitalized with influenza-associated conditions. Two independent authors selected relevant articles. We calculated pooled IVE against any and (sub)type specific influenza among all adults, and stratified by age group (18-64 and 65 years and above) using random-effects models.Results We identified 3411 publications and 30 met our inclusion criteria. Between 2010-11 and 2014-15, the pooled seasonal IVE was 41% (95%CI:34;48) for any influenza (51% (95%CI:44;58) among people aged 18-64y and 37% (95%CI:30;44) among ≥65 years). IVE was 48% (95%CI:37;59),37% (95%CI:24;50) and 38% (95%CI:23;53) against influenza A(H1N1)pdm09, A(H3N2) and B, respectively. Among persons aged ≥65 year, IVE against A(H3N2) was 43% (95%CI:33;53) in seasons when circulating and vaccine strains were antigenically similar and 14% (95%CI:-3;30) when A(H3N2) variant viruses predominated.Conclusions Influenza vaccines provided moderate protection against influenza-associated hospitalizations among adults. They seemed to provide low protection among elderly in seasons where vaccine and circulating A(H3N2) strains were antigenically variant.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.jinf.2017.09.010

Cites

85 of 85 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
Comparison of PubMed, Scopus, Web of Science, and Google Scholar: strengths and weaknesses
Falagas, M. E., Pitsouni, E. I., Malietzis, G. A., & Pappas, G. (2008) · The FASEB Journal · doi:10.1096/fj.07-9492lsf · Cited by 5,039
Prevention and Control of Influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Fiore, A. E., Shay, D. K., Broder, K. R., Iskander, J. K., Uyeki, T. M., Mootrey, G., Bresee, J. S., & Cox, N. S. (2001) · PsycEXTRA Dataset · doi:10.1037/e548312006-001 · Cited by 5,006
Investigating and dealing with publication and other biases in meta-analysis
Sterne, J. A. C., Egger, M., & Smith, G. D. (2001) · BMJ · doi:10.1136/bmj.323.7304.101 · Cited by 2,225
Vaccine hesitancy
Dubé, È., Laberge, C., Guay, M., Bramadat, P. A., Roy, R., & Bettinger, J. A. (2013) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.24657 · Cited by 2,178
The annual impact of seasonal influenza in the US: Measuring disease burden and costs
Molinari, N., Ortega‐Sanchez, I. R., Messonnier, M. L., Thompson, W., WORTLEY, P. M., Weintraub, E., & Bridges, C. B. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.03.046 · Cited by 1,722
Undue reliance on I 2 in assessing heterogeneity may mislead
Rücker, G., Schwarzer, G., Carpenter, J. R., & Schumacher, M. (2008) · BMC Medical Research Methodology · doi:10.1186/1471-2288-8-79 · Cited by 1,287
Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies
Belongia, E. A., Simpson, M. D., King, J. P., Sundaram, M. E., Kelley, N. S., Osterholm, M. T., & McLean, H. Q. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)00129-8 · Cited by 720

Show all 85 references

Research works printed but not linked: 1

World Health Organization, 2005, Influenza vaccines. WHO position paper, Wkly Epidemiol Rec, 80, 279

Sorted by citations

Influenza
Uyeki, T. M., Hui, D. S. C., Zambon, M. C. F. A., Wentworth, D. E., & Monto, A. S. (2022) · The Lancet · doi:10.1016/s0140-6736(22)00982-5 · Cited by 596
Immunosenescence and human vaccine immune responses
Crooke, S. N., Ovsyannikova, I. G., Poland, G. A., & Kennedy, R. B. (2019) · Immunity & Ageing · doi:10.1186/s12979-019-0164-9 · Cited by 530
B Cell Immunosenescence
Frasca, D., Diaz, A., Romero, M., Garcia, D., & Blomberg, B. B. (2020) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-011620-034148 · Cited by 232
Influenza Vaccine Effectiveness in Preventing Influenza-associated Hospitalizations During Pregnancy: A Multi-country Retrospective Test Negative Design Study, 2010–2016
Thompson, M. G., Kwong, J. C., Regan, A. K., Katz, M. A., Drews, S. J., Azziz‐Baumgartner, E., Klein, N. P., Chung, H., Effler, P. V., Feldman, B., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy737 · Cited by 191
Viral Infections, the Microbiome, and Probiotics
Harper, A., Vijayakumar, V., Ouwehand, A. C., ter Haar, J., Obis, D., Espadaler, J., Binda, S., Desiraju, S., & Day, R. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.596166 · Cited by 177
Understanding immunosenescence and its impact on vaccination of older adults
Allen, J. C., Toapanta, F. R., Chen, W. H., & Tennant, S. M. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.11.002 · Cited by 161
4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Care in Diabetes—2024
ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Cusi, K. J., Ekhlaspour, L., Fleming, T. K., Hilliard, M. E., Johnson, E. L., et al. (2023) · Diabetes Care · doi:10.2337/dc24-s004 · Cited by 173
Influenza Viruses and Vaccines: The Role of Vaccine Effectiveness Studies for Evaluation of the Benefits of Influenza Vaccines
Trombetta, C. M., Kistner, O., Montomoli, E., Viviani, S., & Marchi, S. (2022) · Vaccines · doi:10.3390/vaccines10050714 · Cited by 149
Influenza vaccine effectiveness in preventing influenza-associated intensive care admissions and attenuating severe disease among adults in New Zealand 2012–2015
Thompson, M. G., Pierse, N., Huang, Q. S., Prasad, N., Duque, J., Newbern, E. C., Baker, M. G., Turner, N. M., & McArthur, C. J. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.07.028 · Cited by 127
Interim 2017/18 influenza seasonal vaccine effectiveness: combined results from five European studies
Rondy, M., Kissling, E., Emborg, H., Gherasim, A., Pebody, R. G., Trebbien, R., Pozo, F., Larrauri, A., McMenamin, J., Valenciano, M., et al. (2018) · Eurosurveillance · doi:10.2807/1560-7917.es.2018.23.9.18-00086 · Cited by 122
Effectiveness of the MF59‐adjuvanted trivalent or quadrivalent seasonal influenza vaccine among adults 65 years of age or older, a systematic review and meta‐analysis
Coleman, B. L., Sanderson, R., Haag, M. D. M., & McGovern, I. (2021) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12871 · Cited by 117
Influenza vaccination: protecting the most vulnerable
Tanner, A. R., Dorey, R. B., Brendish, N. J., & Clark, T. W. (2021) · European Respiratory Review · doi:10.1183/16000617.0258-2020 · Cited by 114
Comparative Immunogenicity of Several Enhanced Influenza Vaccine Options for Older Adults: A Randomized, Controlled Trial
Cowling, B. J., Perera, R. A. P. M., Valkenburg, S. A., Leung, N. H. L., Iuliano, A. D., Tam, Y. H., Wong, J. H. F., Fang, V. J., Li, A. P. Y., So, H. C., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciz1034 · Cited by 110
An influenza hemagglutinin stem nanoparticle vaccine induces cross-group 1 neutralizing antibodies in healthy adults
Widge, A. T., Hofstetter, A. R., Houser, K. V., Awan, S. F., Chen, G. L., Florez, M. C. B., Berkowitz, N. M., Mendoza, F. H., Hendel, C. S., Holman, L. A., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.ade4790 · Cited by 97
Progress and Pitfalls in the Quest for Effective SARS-CoV-2 (COVID-19) Vaccines
Flanagan, K. L., Best, E., Crawford, N. W., Giles, M., Koirala, A., Macartney, K. K., Russell, F. M., Teh, B. W., & Wen, S. C.-H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.579250 · Cited by 96
Variable seasonal influenza vaccine effectiveness across geographical regions, age groups and levels of vaccine antigenic similarity with circulating virus strains: A systematic review and meta-analysis of the evidence from test-negative design studies after the 2009/10 influenza pandemic
Okoli, G. N., Racovitan, F., Abdulwahid, T., Righolt, C. H., & Mahmud, S. M. (2021) · Vaccine · doi:10.1016/j.vaccine.2021.01.032 · Cited by 87
Challenges and opportunities for antiviral monoclonal antibodies as COVID-19 therapy
Cruz-Teran, C. A., Tiruthani, K., McSweeney, M. D., Ma, A. L., Pickles, R. J., & Lai, S. K. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.12.004 · Cited by 90
Influenza Vaccines: Successes and Continuing Challenges
Becker, T., Elbahesh, H., Reperant, L. A., Rimmelzwaan, G. F., & Osterhaus, A. D. M. E. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab269 · Cited by 83
Health Information Sources and the Influenza Vaccination: The Mediating Roles of Perceived Vaccine Efficacy and Safety
Hwang, J. (2020) · Journal of Health Communication · doi:10.1080/10810730.2020.1840675 · Cited by 82
Influenza vaccine effectiveness against influenza-associated hospitalization in children: A systematic review and meta-analysis
Kalligeros, M., Shehadeh, F., Mylona, E. K., Dapaah-Afriyie, C., van Aalst, R., Chit, A., & Mylonakis, E. E. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.02.049 · Cited by 82
Burden, effectiveness and safety of influenza vaccines in elderly, paediatric and pregnant populations
Sullivan, S. G., Price, O. H., & Regan, A. K. (2019) · Therapeutic Advances in Vaccines and Immunotherapy · doi:10.1177/2515135519826481 · Cited by 79
Influenza Vaccination in Older Adults: Recent Innovations and Practical Applications
Andrew, M. K., Bowles, S. K., Pawelec, G., Haynes, L., Kuchel, G. A., McNeil, S., & McElhaney, J. E. (2018) · Drugs & Aging · doi:10.1007/s40266-018-0597-4 · Cited by 76
Comparative immunogenicity of enhanced seasonal influenza vaccines in older adults: a systematic review and meta-analysis
Ng, T. W. Y., Cowling, B. J., Gao, H., & Thompson, M. G. (2018) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiy720 · Cited by 76
Risk of Severe Influenza Among Adults With Chronic Medical Conditions
Walker, T. A., Waite, B., Thompson, M. G., McArthur, C. J., Wong, C., Baker, M. G., Wood, T., Haubrock, J., Roberts, S., Gross, D., et al. (2019) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiz570 · Cited by 64
Immunogenicity of standard, high-dose, MF59-adjuvanted, and recombinant-HA seasonal influenza vaccination in older adults
Li, A. P. Y., Cohen, C. A., Leung, N., Fang, V. J., Gangappa, S., Sambhara, S. R., Levine, M. Z., Iuliano, A. D., Perera, R. A. P. M., Ip, D., et al. (2021) · npj Vaccines · doi:10.1038/s41541-021-00289-5 · Cited by 63
Guideline for the Management of Diabetes Mellitus in the Elderly in China (2024 Edition)
Guo, L., & Xiao, X. (2024) · Aging Medicine · doi:10.1002/agm2.12294 · Cited by 69
Influenza Vaccine Effectiveness in Inpatient and Outpatient Settings in the United States, 2015–2018
Tenforde, M. W., Chung, J. R., Smith, E. R., Talbot, H. K., Trabue, C. H., Zimmerman, R. K., Silveira, F. P., Gaglani, M., Murthy, K., Monto, A. S., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa407 · Cited by 60
Real-world effectiveness of seasonal influenza vaccination and age as effect modifier: A systematic review, meta-analysis and meta-regression of test-negative design studies
Guo, J., Chen, X., Guo, Y., Liu, M., Li, P., Tao, Y., Liu, Z., Yang, Z., Zhan, S., & Sun, F. (2024) · Vaccine · doi:10.1016/j.vaccine.2024.02.059 · Cited by 61
Age-related changes in the immune system and challenges for the development of age-specific vaccines
Doherty, M. T., Weinberger, B., Didierlaurent, A. M., & Lambert, P. (2025) · Annals of Medicine · doi:10.1080/07853890.2025.2477300 · Cited by 69
Influenza: Diabetes as a risk factor for severe related-outcomes and the effectiveness of vaccination in diabetic population. A meta-analysis of observational studies
Dicembrini, I., Silverii, G. A., Clerico, A., Fornengo, R., Gabutti, G., Sordi, V., Tafuri, S., Peruzzi, O., & Mannucci, E. (2023) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2023.03.016 · Cited by 59
Backward transmission of COVID-19 from humans to animals may propagate reinfections and induce vaccine failure
He, S., Han, J., & Lichtfouse, É. (2021) · Environmental Chemistry Letters · doi:10.1007/s10311-020-01140-4 · Cited by 51
Effectiveness of Influenza Vaccination in Preventing Hospitalization Due to Influenza in Children: A Systematic Review and Meta-analysis
Boddington, N. L., Pearson, I., Whitaker, H., Mangtani, P., & Pebody, R. G. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab270 · Cited by 48
Using the health belief model to identify barriers to seasonal influenza vaccination among Australian adults in 2019
Trent, M. J., Salmon, D. A., & MacIntyre, C. R. (2021) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12843 · Cited by 48
Influenza vaccination for elderly, vulnerable and high-risk subjects: a narrative review and expert opinion
Incalzi, R. A., Consoli, A., Lopalco, P., Maggi, S., Sesti, G., Veronese, N., & Volpe, M. (2023) · Internal and Emergency Medicine · doi:10.1007/s11739-023-03456-9 · Cited by 47
Acceptability of seasonal influenza vaccines among health care workers in Vietnam in 2017
Nguyen, T. T. M., Lafond, K. E., Nguyen, T. X., Tran, P. D., Nguyen, H. M., Ha, V. T. C., Do, T. T., Ha, N. T., Seward, J. F., & McFarland, J. W. (2020) · Vaccine · doi:10.1016/j.vaccine.2019.12.047 · Cited by 46
Electronic Nudges to Increase Influenza Vaccination in Patients With Chronic Diseases
Johansen, N. D., Vaduganathan, M., Bhatt, A. S., Modin, D., Chatur, S., Claggett, B. L., Janstrup, K. H., Larsen, C. S., Larsen, L., Wiese, L., et al. (2024) · JAMA · doi:10.1001/jama.2024.21060 · Cited by 41
Protection against influenza hospitalizations from enhanced influenza vaccines among older adults: A systematic review and network meta‐analysis
Ferdinands, J. M., Blanton, L., Alyanak, E., Chung, J. R., Trujillo, L., Taliano, J. M., Morgan, R. L., Fry, A. M., & Grohskopf, L. A. (2024) · Journal of the American Geriatrics Society · doi:10.1111/jgs.19176 · Cited by 41
Comparison of influenza-specific neutralizing antibody titers determined using different assay readouts and hemagglutination inhibition titers: good correlation but poor agreement
Sicca, F., Martinuzzi, D., Montomoli, E., & Huckriede, A. L. W. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.01.088 · Cited by 40
Influenza: seasonality and travel-related considerations
Kakoullis, L., Steffen, R. J., Osterhaus, A. D. M. E., Goeijenbier, M., Rao, S. R., Koiso, S., Hyle, E. P., Ryan, E. T., LaRocque, R. C., & Chen, L. H. (2023) · Journal of Travel Medicine · doi:10.1093/jtm/taad102 · Cited by 40
Influenza vaccination and prevention of antimicrobial resistance
Esposito, S., & Principi, N. (2018) · Expert Review of Vaccines · doi:10.1080/14760584.2018.1525298 · Cited by 36
Combination of STING Pathway Agonist With Saponin Is an Effective Adjuvant in Immunosenescent Mice
Vassilieva, E. V., Taylor, D., & Compans, R. W. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.03006 · Cited by 35
Impacts of free vaccination policy and associated factors on influenza vaccination behavior of the elderly in China: A quasi-experimental study
Jiang, X., Shang, X., Lin, J., Zhao, Y., Wang, W., & Qiu, Y. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.12.040 · Cited by 35
Sex-specific effects of aging on humoral immune responses to repeated influenza vaccination in older adults
Shapiro, J. R., Li, H., Morgan, R., Chen, Y., Kuo, H., Ning, X., Shea, P., Wu, C., Merport, K., Saldanha, R., et al. (2021) · npj Vaccines · doi:10.1038/s41541-021-00412-6 · Cited by 34
Low 2016/17 season vaccine effectiveness against hospitalised influenza A(H3N2) among elderly: awareness warranted for 2017/18 season
Rondy, M., Gherasim, A., Casado, I., Launay, O., Rizzo, C., Pițigoi, D., Mickienė, A., Marbus, S. D., Machado, A., Syrjänen, R. K., et al. (2017) · Eurosurveillance · doi:10.2807/1560-7917.es.2017.22.41.17-00645 · Cited by 34
Interpretation of Relative Efficacy and Effectiveness for Influenza Vaccines
Lewis, N. M., Chung, J. R., Uyeki, T. M., Grohskopf, L. A., Ferdinands, J. M., & Patel, M. M. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab1016 · Cited by 34
Adeno‐associated virus‐vectored influenza vaccine elicits neutralizing and Fcγ receptor‐activating antibodies
Demminger, D. E., Walz, L., Dietert, K., Hoffmann, H., Planz, O., Gruber, A. D., von Messling, V., & Wolff, T. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.201910938 · Cited by 32
M2e-Based Influenza Vaccines with Nucleoprotein: A Review
Tan, M. P., Tan, W. S., Alitheen, N. B., & Yap, W. B. (2021) · Vaccines · doi:10.3390/vaccines9070739 · Cited by 30
Protection provided by influenza vaccine against influenza-related hospitalisation in ≥65 year olds: Early experience of introduction of a newly licensed adjuvanted vaccine in England in 2018/19
Pebody, R. G., Whitaker, H., Zhao, H., Andrews, N. J., Ellis, J., Donati, M., & Zambon, M. C. F. A. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.10.032 · Cited by 31
Antibody-mediated NK cell activation as a correlate of immunity against influenza infection
Boudreau, C. M., Burke, J. S., Yousif, A. S., Sangesland, M., Jastrzebski, S. L., Verschoor, C. P., Kuchel, G. A., Lingwood, D., Kleanthous, H., Bruijn, I. D., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40699-8 · Cited by 30
The impact of repeated vaccination using 10-year vaccination history on protection against influenza in older adults: a test-negative design study across the 2010/11 to 2015/16 influenza seasons in Ontario, Canada
Kwong, J. C., Chung, H., Jung, J. K. H., Buchan, S. A., Campigotto, A. J., Campitelli, M. A., Crowcroft, N. S., Gubbay, J. B., Karnauchow, T., Katz, K. C., et al. (2020) · Eurosurveillance · doi:10.2807/1560-7917.es.2020.25.1.1900245 · Cited by 30
The Interplay between Immunosenescence and Microbiota in the Efficacy of Vaccines
Cianci, R., Franza, L., Massaro, M. G., Borriello, R., Vito, F., & Gambassi, G. (2020) · Vaccines · doi:10.3390/vaccines8040636 · Cited by 32
Gut microbiome, Vitamin D, ACE2 interactions are critical factors in immune-senescence and inflammaging: key for vaccine response and severity of COVID-19 infection
Shenoy, S. (2021) · Inflammation Research · doi:10.1007/s00011-021-01510-w · Cited by 31
Impact of influenza vaccine in reduction of incidence and severity of influenza-like illness
Khan, R., Ahmed, A., Zeitounie, R., & Khandekar, R. B. (2021) · Eastern Mediterranean Health Journal · doi:10.26719/emhj.21.041 · Cited by 29
Seasonal Influenza Vaccine Effectiveness in Persons Aged 15–64 Years: A Systematic Review and Meta-Analysis
Martins, J. P., Santos, M., Martins, A. M., Felgueiras, M. M., & Santos, R. (2023) · Vaccines · doi:10.3390/vaccines11081322 · Cited by 31
Seasonal influenza immunisation: Strategies for older adults
Schaffner, W., Buynder, P. G. V., McNeil, S., & Osterhaus, A. D. M. E. (2018) · International Journal of Clinical Practice · doi:10.1111/ijcp.13249 · Cited by 30
Influenza Vaccine Effectiveness in Preventing Hospitalizations in Older Patients With Chronic Obstructive Pulmonary Disease
Gershon, A. S., Chung, H., Porter, J., Campitelli, M. A., Buchan, S. A., Schwartz, K. L., Crowcroft, N. S., Campigotto, A. J., Gubbay, J. B., Karnauchow, T., et al. (2019) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiz419 · Cited by 29
Selective Breeding for Disease-Resistant PRNP Variants to Manage Chronic Wasting Disease in Farmed Whitetail Deer
Haley, N. J., Donner, R., Merrett, K., Miller, M. W., & Senior, K. (2021) · Genes · doi:10.3390/genes12091396 · Cited by 29
Mucosal correlates of protection after influenza viral challenge of vaccinated and unvaccinated healthy volunteers
Bean, R., Giurgea, L. T., Han, A., Czajkowski, L. M., Cervantes-Medina, A., Gouzoulis, M. A., Mateja, A., Hunsberger, S., Reed, S., Athota, R., et al. (2024) · mBio · doi:10.1128/mbio.02372-23 · Cited by 28
The burden of influenza in older adults: meeting the challenge
Bartoszko, J. J., & Loeb, M. B. (2019) · Aging Clinical and Experimental Research · doi:10.1007/s40520-019-01279-3 · Cited by 28
Influenza vaccine effectiveness against hospitalizations in children and older adults—Data from South America, 2013–2017. A test negative design
Arriola, C. S., Omeiri, N. E., Azziz‐Baumgartner, E., Thompson, M. G., Sotomayor, V., Fasce, R., Horoch, M. V., Olalla, J. E. C., de Almeida, W. A. F., Palacios, J., et al. (2019) · Vaccine X · doi:10.1016/j.jvacx.2019.100047 · Cited by 28
Repeated vaccination against matched H3N2 influenza virus gives less protection than single vaccination in ferrets
Music, N., Tzeng, W., Gross, F. L., Levine, M. Z., Xu, X., Shieh, W., Tumpey, T. M., Katz, J. M., & York, I. A. (2019) · npj Vaccines · doi:10.1038/s41541-019-0123-7 · Cited by 26
COVID-19 Vaccines in Older Adults
Liang, C., Lee, W., Peng, L., Meng, L., Hsiao, F., & Chen, L. (2022) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2022.03.006 · Cited by 27
Influenza and COVID-19 co-infection and vaccine effectiveness against severe cases: a mathematical modeling study
Liang, J., Wang, Y., Lin, Z., He, W., Sun, J., Li, Q., Zhang, M., Chang, Z., Guo, Y., Zeng, W., et al. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1347710 · Cited by 26
COVID-19 vaccine development and the way forward
Arora, N., & Das, M. K. (2020) · Indian Journal of Public Health · doi:10.4103/ijph.ijph_520_20 · Cited by 23
Magnesium treatment on methylation changes of transmembrane serine protease 2 (TMPRSS2)
Fan, L., Zhu, X., Zheng, Y., Zhang, W., Seidner, D. L., Ness, R. M., Murff, H. J., Yu, C., Huang, X., Shrubsole, M. J., et al. (2021) · Nutrition · doi:10.1016/j.nut.2021.111340 · Cited by 23
Discordance between Serum Neutralizing Antibody Titers and the Recovery from COVID-19
Kalkan-Yazıcı, M., Koç, M. M., Çetin, N. S., Karaaslan, E., Okay, G., Durdu, B., Sümbül, B., & Doymaz, M. Z. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2000840 · Cited by 22
Cytomegalovirus Seropositivity in Older Adults Changes the T Cell Repertoire but Does Not Prevent Antibody or Cellular Responses to SARS-CoV-2 Vaccination
Breznik, J. A., Huynh, A., Zhang, A., Bilaver, L., Bhakta, H., Stacey, H. D., Ang, J. C., Bramson, J. L., Nazy, I., Miller, M. S., et al. (2022) · The Journal of Immunology · doi:10.4049/jimmunol.2200369 · Cited by 23
Efficacy and Safety of Vaccinations in Geriatric Patients: A Literature Review
Ciarambino, T., Crispino, P., Buono, P., Giordano, V., Trama, U., Iodice, V., Leoncini, L., & Giordano, M. (2023) · Vaccines · doi:10.3390/vaccines11091412 · Cited by 24
Electronic nudges for sustained influenza vaccination uptake in older adults: the nationwide randomized NUDGE-FLU-2 trial
Johansen, N. D., Vaduganathan, M., Bhatt, A. S., Modin, D., Chatur, S., Claggett, B. L., Janstrup, K. H., Larsen, C. S., Larsen, L., Wiese, L., et al. (2024) · Nature Medicine · doi:10.1038/s41591-024-03202-4 · Cited by 22
Multilayer Adjuvanted Influenza Protein Nanoparticles Improve Intranasal Delivery and Antigen-Specific Immunity
Park, J., Pho, T., Bhatnagar, N., Mai, L. D., Rodriguez-Otero, M. R., Pal, S. S., Le, C. T. T., Jenison, S. E., Li, C., May, G. A., et al. (2025) · ACS Nano · doi:10.1021/acsnano.4c14735 · Cited by 21
Vaccine effectiveness against influenza A(H3N2) and B among laboratory‐confirmed, hospitalised older adults, Europe, 2017‐18: A season of B lineage mismatched to the trivalent vaccine
Rose, A. M., Kissling, E., Gherasim, A., Casado, I., Bella, A., Launay, O., Lazăr, M., Marbus, S. D., Kuliešė, M., Syrjänen, R. K., et al. (2020) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12714 · Cited by 21
Influenza Vaccine Effectiveness Against All-Cause Mortality Following Laboratory-Confirmed Influenza in Older Adults, 2010–2011 to 2015–2016 Seasons in Ontario, Canada
Chung, H., Buchan, S. A., Campigotto, A. J., Campitelli, M. A., Crowcroft, N. S., Dubey, V., Gubbay, J. B., Karnauchow, T., Katz, K. C., McGeer, A., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1862 · Cited by 21
Beyond the new normal: Assessing the feasibility of vaccine-based suppression of SARS-CoV-2
Stoddard, M., Sarkar, S., Lin, Y., Nolan, R. P., White, D. E., White, L. F., Hochberg, N. S., & Chakravarty, A. (2021) · PLoS ONE · doi:10.1371/journal.pone.0254734 · Cited by 21
Potential SARS-CoV-2 vaccines: Concept, progress, and challenges
Hosseini, S. A., Zahedipour, F., Mirzaei, H., & Oskuee, R. K. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107622 · Cited by 26
Spotlight influenza: Estimation of influenza vaccine effectiveness in elderly people with assessment of residual confounding by negative control outcomes, Finland, 2012/13 to 2019/20
Baum, U., Kulathinal, S., & Auranen, K. J. (2021) · Eurosurveillance · doi:10.2807/1560-7917.es.2021.26.36.2100054 · Cited by 20
Knowledge, attitudes, perceptions, and practice toward seasonal influenza and its vaccine: A cross-sectional study from a country of conflict
Ahmed, W. S., Farha, R. K. A., Halboup, A. M., Alshargabi, A., Al-Mohamadi, A., Abu-rish, E. Y., Zawiah, M., Al-Ashbat, Y. K., & Al‐Jamei, S. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1030391 · Cited by 20
Gastroenteritis and respiratory infection outbreaks in French nursing homes from 2007 to 2018: Morbidity and all-cause lethality according to the individual characteristics of residents
Gaspard, P., Mosnier, A., Simon, L., Ali-Brandmeyer, O., Rabaud, C., Larocca, S., Heck, B., Aho, S., Pothier, P., & Ambert‐Balay, K. (2019) · PLoS ONE · doi:10.1371/journal.pone.0222321 · Cited by 20
Trivalent mRNA vaccine-candidate against seasonal flu with cross-specific humoral immune response
Mazunina, E. P., Gushchin, V. А., Kleymenov, D. A., Siniavin, A. E., Ei, B., Шмаров, М. М., Мукашева, Е. А., Bykonia, E. N., Kozlova, S. R., Evgrafova, E. A., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1381508 · Cited by 19
Effectiveness of influenza vaccination to prevent severe disease: a systematic review and meta-analysis of test-negative design studies
Yegorov, S., Patel, O. D., Sharma, H., Khan, T., Gupta, R., Yao, M., Sritharan, A., Silverman, N., Pullenayegum, E., Miller, M. S., et al. (2025) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2025.09.023 · Cited by 19
Influenza Vaccination and Hospitalization Outcomes Among Older Patients With Cardiovascular or Respiratory Diseases
Pang, Y., Wang, Q., Lv, M., Yu, M., Lü, M., Huang, Y., Wu, J., & Xie, Z. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa493 · Cited by 19
Modelling of optimal timing for influenza vaccination as a function of intraseasonal waning of immunity and vaccine coverage
Costantino, V., Trent, M. J., & MacIntyre, C. R. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.08.069 · Cited by 19
Assessment of the benefits of seasonal influenza vaccination: Elements of a framework to interpret estimates of vaccine effectiveness and support robust decision‐making and communication
Hollingsworth, R. C., Guerche‐Séblain, C. E., Tsai, T. F., Vasiliev, Y. M., Lee, S., Bright, H., & Barbosa, P. (2020) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12786 · Cited by 19
Effectiveness of inactivated influenza vaccine against laboratory-confirmed influenza pneumonia among adults aged ≥65 years in Japan
Suzuki, M., Katsurada, N., Le, M. N., Kaneko, N., Yaegashi, M., Hosokawa, N., Otsuka, Y., Aoshima, M., Yoshida, L., & Morimoto, K. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.04.037 · Cited by 19
How Can We Improve the Vaccination Response in Older People? Part II: Targeting Immunosenescence of Adaptive Immunity Cells
Garnica, M., Aiello, A., Ligotti, M. E., Accardi, G., Arasanz, H., Bocanegra, A., Blanco, E., Calabrò, A., Chocarro, L., Echaide, M., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179797 · Cited by 21
The influenza hemagglutinin stem antibody CR9114: Evidence for a narrow evolutionary path towards universal protection
Beukenhorst, A. L., Frallicciardi, J., Koch, C. M., Klap, J. M., Phillips, A. M., Desai, M. M., Wichapong, K., Nicolaes, G. A. F., Koudstaal, W., Alter, G., et al. (2022) · Frontiers in Virology · doi:10.3389/fviro.2022.1049134 · Cited by 18
Phase 1, randomized, rater and participant blinded placebo-controlled study of the safety, reactogenicity, tolerability and immunogenicity of H1N1 influenza vaccine delivered by VX-103 (a MIMIX microneedle patch [MAP] system) in healthy adults
Garg, N., Tellier, G., Vale, N., Kluge, J., Portman, J. L., Markowska, A., & Tussey, L. (2024) · PLoS ONE · doi:10.1371/journal.pone.0303450 · Cited by 22
Comparing Influenza Vaccine Types: The Path Toward Improved Influenza Vaccine Strategies
Flannery, B. L., & Fry, A. M. (2018) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiy717 · Cited by 18
Distinct Functional Humoral Immune Responses Are Induced after Live Attenuated and Inactivated Seasonal Influenza Vaccination
Tong, X., Deng, Y., Cizmeci, D., Fontana, L., Carlock, M. A., Hanley, H. B., McNamara, R. P., Lingwood, D., Ross, T. M., & Alter, G. (2023) · The Journal of Immunology · doi:10.4049/jimmunol.2200956 · Cited by 18
Age- and sex-related variations in extracellular vesicle profiling for the assessment of cardiovascular risk: the EVaging index
Burrello, J., Goi, J., Burrello, A., Vacchi, E., Rendon-Angel, A., Lazzarini, E., Bianco, G., Limongelli, V., Vassalli, G., Cereda, C. W., et al. (2024) · npj Aging · doi:10.1038/s41514-024-00189-7 · Cited by 17
Effectiveness of 2023 southern hemisphere influenza vaccines against severe influenza-associated illness: pooled estimates from eight countries using the test-negative design
Gharpure, R. V., Regan, A. K., Nogareda, F., Cheng, A. C., Blyth, C. C., George, S. S., Huang, Q. S., Wood, T., Anglemyer, A. T., Prasert, K., et al. (2025) · The Lancet Global Health · doi:10.1016/s2214-109x(24)00473-x · Cited by 16
Seasonal influenza vaccination expands hemagglutinin-specific antibody breadth to older and future A/H3N2 viruses
Ertesvåg, N. U., Cox, R. J., Lartey, S. L., Mohn, K. G.-I., Brokstad, K. A., & Trieu, M.-C. (2022) · npj Vaccines · doi:10.1038/s41541-022-00490-0 · Cited by 16
Advanced biological age is associated with improved antibody responses in older high-dose influenza vaccine recipients over four consecutive seasons
Verschoor, C. P., Belsky, D. W., Andrew, M. K., Haynes, L., Loeb, M. B., Pawelec, G., McElhaney, J. E., & Kuchel, G. A. (2022) · Immunity & Ageing · doi:10.1186/s12979-022-00296-7 · Cited by 17
Discrimination of the H1N1 and H5N2 Variants of Influenza A Virus Using an Isomeric Sialic Acid-Conjugated Graphene Field-Effect Transistor
Nazir, S., Kim, K. H., Kim, L., Seo, S. E., Bae, P. K., An, J. E., & Kwon, O. S. (2023) · Analytical Chemistry · doi:10.1021/acs.analchem.2c04273 · Cited by 16
Influenza Vaccine Effectiveness Against Influenza-Related Mortality in Australian Hospitalized Patients: A Propensity Score Analysis
Nation, M. L., Moss, R. G., Spittal, M. J., Kotsimbos, T. C., Kelly, P., & Cheng, A. C. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciz1238 · Cited by 16
Winter Is Coming! Clinical, Immunologic, and Practical Considerations for Vaccinating Patients With Inflammatory Bowel Disease During the Coronavirus Disease-2019 Pandemic
MELMED, G. Y., Rubin, D. T., & McGovern, D. P. B. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.10.013 · Cited by 14
Vaccine-Induced Immunity Elicited by Microneedle Delivery of Influenza Ectodomain Matrix Protein 2 Virus-like Particle (M2e VLP)-Loaded PLGA Nanoparticles
Gomes, K. B., Vijayanand, S., Bagwe, P., Menon, I., Kale, A., Patil, S., Kang, S., Uddin, M. N., & D’Souza, M. J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310612 · Cited by 14
Systematic review of influenza vaccine effectiveness against laboratory-confirmed influenza among older adults living in aged care facilities
Moa, A., Kunasekaran, M. P., Akhtar, Z., Costantino, V., & MacIntyre, C. R. (2023) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2023.2271304 · Cited by 17
Influenza vaccination mitigates severe complications in hospitalized patients: A ten-year observational study, Spain, 2009-2019
Mangas-Moro, A., Zamarrón, E., Carpio, C., Álvarez-Sala, R., Arribas-López, J. R., & Prados, C. (2023) · American Journal of Infection Control · doi:10.1016/j.ajic.2023.11.009 · Cited by 14
The influence of demographics on influenza vaccine awareness and hesitancy among adults visiting educational hospital in Saudi Arabia
Alzeer, A. A., Alfantoukh, L., Theneyan, A., Eid, F. B., Almangour, T. A., Alshememry, A. K., & Alhossan, A. (2021) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2021.01.001 · Cited by 14
Real-World Evidence in Cost-Effectiveness Analysis of Enhanced Influenza Vaccines in Adults ≥ 65 Years of Age: Literature Review and Expert Opinion
Postma, M. J., Fisman, D. N., Giglio, N., Márquez-Peláez, S., Nguyen, V. H., Pugliese, A., Ruiz-Aragón, J., Urueña, A., & Mould-Quevedo, J. F. (2023) · Vaccines · doi:10.3390/vaccines11061089 · Cited by 16

Authors: Rondy, M., El Omeiri, N., Thompson, M. G., Levêque, A., Moren, A., & Sullivan, S. G.
Affiliations: Université de Bordeaux (FR)
Centers for Disease Control and Prevention (US)
Peter Doherty Institute (AU)
Corresponding author: Rondy, Marc
ORCID: Rondy, Marc
Thompson, Mark G.
Moren, Alain
Sullivan, Sheena G.
Venue: Journal of Infection
Publisher: Elsevier BV
Published: 2017-11
Volume: 75
Issue: 5
Pages: 381-394
ISSN: 0163-4453 (ISSN-L)
DOI: 10.1016/j.jinf.2017.09.010
PMC: PMC5912669
OpenAlex: W2754200907
Cited by: 247
References: 85
Citations by year: 2026: 20 · 2025: 31 · 2024: 29 · 2023: 34 · 2022: 30 · 2021: 35 · 2020: 38 · 2019: 16 · 2018: 13 · 2017: 1
FWCI: 2.46
Type: journal article
Language: en
Open access: green
europepmc.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: Journal of Infection (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
Funders: National Institutes of Health (CC999999)
Topics: Health Sciences › Medicine › Epidemiology › Influenza Virus Research Studies
Health Sciences › Medicine › Epidemiology › Respiratory viral infections research
Social Sciences › Health › Vaccine Coverage and Hesitancy
Keywords: influenza vaccine effectiveness, seasonal influenza vaccine, influenza-associated hospitalizations, test-negative design, influenza A(H1N1)pdm09, H3N2, influenza B, antigenic mismatch, older adults, adults
MeSH terms: Immunogenicity, Vaccine, Adult, Hospitalization, Humans, Influenza, Human, Influenza Vaccines, Case-Control Studies, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Effectiveness of influenza vaccines in preventing severe influenza illness among adults: A systematic review and meta- analysis of test-negative design case-control studies

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks